Skip to content

Company · founded 2012

Intravacc (Netherlands)

De Bilt, Netherlands · intravacc.nl

Manage this page

Citations, last 5 years: 465
Works, last 5 years: 46
h-index: 75
Scientists listed: 12
Grants since 2016: 8

Grants received

2022–2026 · contract · N01

DEVELOPMENT OF AN INTRANASAL VACCINE AGAINST GONORRHEA

Dinja Oosterhoff · Intravacc (Netherlands) · funded by National Institutes of Health

$756.8k

2022–2026 · contract · N01

Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases

Dinja Oosterhoff · Intravacc (Netherlands) · funded by National Institutes of Health

$2.7M

2022–2023 · contract · N01

DEVELOPMENT OF AN INTRANASAL VACCINE AGAINST GONORRHEA

Dinja Oosterhoff · Intravacc (Netherlands) · funded by National Institutes of Health

$2M

2022–2026 · contract · N01

Advanced Development of Vaccine Candidates for Biodefense and Emerging Antibiotic-Resistant Infectious Diseases

Corine Kruiswijk · Intravacc (Netherlands) · funded by National Institutes of Health

$1.2M

2020–2025 · contract · N01

Advanced Development of a Vaccine for Acute Flaccid Myelitis Associated with Enterovirus D68

Dinja Oosterhoff · Intravacc (Netherlands) · funded by National Institutes of Health

$1.1M

2020–2024 · contract · N01

Advanced Development of a Vaccine for Acute Flaccid Myelitis Associated with Enterovirus D68

Dinja Oosterhoff · Intravacc (Netherlands) · funded by National Institutes of Health

$194.5k

2020–2024 · contract · N01

Advanced Development of a Vaccine for Acute Flaccid Myelitis Associated with Enterovirus D68

Dinja Oosterhoff · Intravacc (Netherlands) · funded by National Institutes of Health

$5M

2020–2026 · contract · N01

Advanced Development of a Vaccine for Acute Flaccid Myelitis Associated with Enterovirus D68

Dinja Oosterhoff · Intravacc (Netherlands) · funded by National Institutes of Health

$1M